Table 2. Surgical procedures and follow-up.
| Perioperative details | Value, n (%) |
|---|---|
| Patients, n | 51 |
| Operative approach | |
| Video-assisted thoracoscopic wedge resection | 32 (62.7) |
| Video-assisted thoracoscopic segmentectomy | 6 (11.8) |
| Video-assisted thoracoscopic lobectomy | 13 (25.5) |
| Primary surgical indications | |
| Failure of antifungal therapy | 41 (80.4) |
| Preparation for HSCT | 3 (5.9) |
| Treating hemoptysis | 7 (13.7) |
| Duration of the surgical procedure, min (mean ± SD) | 110.24±38.12 |
| Intraoperative blood loss, mL (mean ± SD) | 112.35±87.85 |
| Postoperative hospital stay, day (mean ± SD) | 7.75±3.27 |
| Postoperative complications | |
| Prolonged air leak (≥5 days) | 6 (11.8) |
| Pneumonia | 1 (2.0) |
| Reoperation for bleeding | 0 (0) |
| Excessive effusion (total drainage volume ≥1,000 mL) | 4 (7.8) |
| Follow-up treatments | |
| Chemotherapy | 46 (90.2) |
| HSCT | 19 (37.3) |
| Prophylactic antifungal therapy during chemotherapy or HSCT | 27 (52.9) |
| 30-day mortality | 0 (0) |
| Recurrence | 0 (0) |
HSCT, hematopoietic stem cell transplantation.